Lenvatinib and pembrolizumab in advanced endometrial carcinoma (EC): Long-term efficacy and safety update from a phase 1b/2 study Meeting Abstract
| Authors: | Makker, V.; Aghajanian, C.; Cohn, A.; Romeo, M.; Bratos, R.; Brose, M.; Messing, M.; Dutta, L.; Dutcus, C.; Huang, J.; Schmidt, E.; Orlowski, R.; Taylor, M. |
| Abstract Title: | Lenvatinib and pembrolizumab in advanced endometrial carcinoma (EC): Long-term efficacy and safety update from a phase 1b/2 study |
| Meeting Title: | 36th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2021) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 9 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Nov 10-14 |
| Meeting Location: | Washington, DC |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2021-11-01 |
| Start Page: | A381 |
| Language: | English |
| ACCESSION: | WOS:000774877500343 |
| DOI: | 10.1136/jitc-2021-SITC2021.354 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 354 -- Meeting was also presented virtually -- Source: Wos |
